Suppr超能文献

亚临床甲状腺功能减退症患者管理策略对长期临床结局的影响:伞式综述。

The impact of the management strategies for patients with subclinical hypothyroidism on long-term clinical outcomes: An umbrella review.

机构信息

Population and Behavioural Science Division, School of Medicine, University of St Andrews, St Andrews, Scotland, United Kingdom.

出版信息

PLoS One. 2022 May 19;17(5):e0268070. doi: 10.1371/journal.pone.0268070. eCollection 2022.

Abstract

AIM

This umbrella review summarises and compares synthesised evidence on the impact of subclinical hypothyroidism and its management on long-term clinical outcomes.

METHODS

We conducted comprehensive searches on MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Database of Systematic Reviews, JBI Evidence Synthesis, the PROSPERO register, Epistemonikos Database and PDQ Evidence from inception to February and July 2021 using keywords on subclinical hypothyroidism, treatment with levothyroxine, monitoring and primary outcomes (all-cause mortality, cardiovascular events, stroke, frailty fractures and quality of life). Only systematic reviews and meta-analyses on adult patient populations were considered. Study selection, data extraction and quality appraisal using AMSTAR-2 were done independently by two reviewers and discrepancies were resolved through discussion. Overlap across the selected reviews was also assessed, followed by a narrative synthesis of findings.

RESULTS

A total of 763 studies were identified from literature searches; 20 reviews met inclusion criteria. Methodological quality ratings were high (n = 8), moderate (n = 7), and low (n = 5), but no reviews were excluded on this basis. Though there was slight overlap across all reviews, some pairwise comparisons had high corrected covered area scores. Compared to euthyroidism, untreated subclinical hypothyroidism was associated with a higher risk of cardiovascular events or death if Thyroid Stimulating Hormone was above 10mIU/L at baseline. Treatment was associated with a lower risk of death from all causes for patients younger than 70 years and possibly better cognitive and quality of life scores than untreated individuals. Evidence on the risk of strokes and fractures was inconclusive.

CONCLUSION

In the long term, treatment of subclinical hypothyroidism may be beneficial for some patient groups. However, the findings of this review are negatively impacted by the relative sparseness and poor quality of available evidence. Additional large and adequately powered studies are needed to investigate this topic further.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO (CRD42021235172).

摘要

目的

本综述总结并比较了亚临床甲状腺功能减退症及其治疗对长期临床结局的影响的综合证据。

方法

我们使用亚临床甲状腺功能减退症、左甲状腺素治疗、监测和主要结局(全因死亡率、心血管事件、中风、脆性骨折和生活质量)的关键词,在 MEDLINE、EMBASE、Scopus、Web of Science、Cochrane 系统评价数据库、JBI 证据综合、PROSPERO 注册、Epistemonikos 数据库和 PDQ 证据从成立到 2021 年 2 月和 7 月进行了全面搜索。仅考虑针对成年患者群体的系统评价和荟萃分析。两名评审员独立进行研究选择、数据提取和 AMSTAR-2 质量评估,通过讨论解决分歧。还评估了所选综述之间的重叠,并对结果进行了叙述性综合。

结果

从文献搜索中总共确定了 763 项研究;20 项综述符合纳入标准。方法学质量评分高(n=8)、中等(n=7)和低(n=5),但没有因此排除任何综述。尽管所有综述都有轻微重叠,但一些两两比较的校正覆盖面积得分较高。与甲状腺功能正常相比,如果基线时甲状腺刺激激素(TSH)超过 10mIU/L,未经治疗的亚临床甲状腺功能减退症与心血管事件或死亡风险增加相关。对于年龄小于 70 岁的患者,治疗与全因死亡率降低相关,并且与未经治疗的个体相比,认知和生活质量评分可能更好。关于中风和骨折风险的证据尚无定论。

结论

从长远来看,亚临床甲状腺功能减退症的治疗可能对某些患者群体有益。然而,本综述的结果受到现有证据相对稀疏和质量差的负面影响。需要进一步开展更大规模和足够效力的研究来进一步探讨这个问题。

系统评价注册

PROSPERO(CRD42021235172)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c822/9119548/91025dae8941/pone.0268070.g001.jpg

相似文献

1
6
Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism.
Cochrane Database Syst Rev. 2019 Jun 25;6(6):CD011009. doi: 10.1002/14651858.CD011009.pub2.
8
Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis.
Thyroid. 2021 May;31(5):740-751. doi: 10.1089/thy.2020.0679. Epub 2020 Dec 29.
9
Relationship Between Subclinical Hypothyroidism in Pregnancy and Hypertensive Disorder of Pregnancy: A Systematic Review and Meta-Analysis.
Front Endocrinol (Lausanne). 2022 Mar 8;13:823710. doi: 10.3389/fendo.2022.823710. eCollection 2022.
10

引用本文的文献

1
When Should the Treatment of Obesity in Thyroid Disease Begin?
Biomedicines. 2025 Jan 10;13(1):157. doi: 10.3390/biomedicines13010157.
2
Exploring the causal factor effects of hypothyroidism on ischemic stroke: a two-sample Mendelian randomization study.
Front Neurol. 2024 Jan 31;15:1322472. doi: 10.3389/fneur.2024.1322472. eCollection 2024.
3
The Western and Chinese exercise training for blood pressure reduction among hypertensive patients: An overview of systematic reviews.
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1327-1341. doi: 10.1111/jch.14610. Epub 2023 Mar 22.

本文引用的文献

3
A Clinical Debate: Subclinical Hypothyroidism.
Int J Endocrinol Metab. 2021 Jul 24;19(3):e115948. doi: 10.5812/ijem.115948. eCollection 2021 Jul.
8
Quality and risk of bias appraisals of systematic reviews are inconsistent across reviewers and centers.
J Clin Epidemiol. 2020 Sep;125:9-15. doi: 10.1016/j.jclinepi.2020.04.026. Epub 2020 May 19.
9
Thyroid disease assessment and management: summary of NICE guidance.
BMJ. 2020 Jan 29;368:m41. doi: 10.1136/bmj.m41.
10
Examining overlap of included studies in meta-reviews: Guidance for using the corrected covered area index.
Res Synth Methods. 2020 Jan;11(1):134-145. doi: 10.1002/jrsm.1390. Epub 2019 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验